Biogen Inc.: Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis (tocilizumab)
Biosimilars have the potential to enable greater access to marketed biologic therapies while generating cost savings and healthcare sustainability
CAMBRIDGE, Mass. and GUANGZHOU, China, April 08, 2021Inc. (Nasdaq: BIIB) and Bio-Thera Solutions, Ltd. (688177.SH) today announced that they entered into a commercialization and license agreement to develop, manufacture and commercialize BAT1806, a Phase 3 clinical stage anti-interleukin-6 (IL-6) receptor monoclonal antibody that is a proposed biosimilar referencing ACTEMRA
1 (tocilizumab).
ACTEMRA s primary indication is for moderate to severe rheumatoid arthritis in adults as well as juvenile idiopathic polyarthritis, systemic juvenile idiopathic arthritis, giant cell arteritis and cytokine release syndrome. In 20
Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
CymaBay Appoints Thomas Wiggans and Janet Dorling to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SAN DIEGO, March 9, 2021 /PRNewswire/ Mitchell, a leading provider of technology, connectivity and information solutions to the Property & Casualty (P&C) claims and Collision Repair industries, today released its first quarter Industry Trends Report for 2021. The report shares important data-driven trends impacting the property and casualty industry, along with expert insights, opinions and guidance that can help businesses navigate this year s new environment.
A year after the COVID crisis abruptly upended life around the world, workers everywhere are anxiously awaiting a return to normal. However, industry experts note the importance of understanding that our future normal may be very different, as changes in commuting, investments in virtual medical care, and the emergence of a hybrid workforce begin to take shape.